Publications by authors named "Lucia Schauf"
Article Synopsis
- Hereditary angioedema (HAE) is a rare genetic condition affecting about 1 in 50,000 people, leading to unpredictable swelling attacks that significantly impact patients' quality of life.
- A survey conducted with 99 patients revealed that anxiety about attack occurrences and physical limitations during attacks are major concerns, though many patients receive regular treatment and are generally satisfied with their therapies.
- Despite high satisfaction levels, 62% of patients showed strong interest in an oral long-term prophylactic (LTP), as it simplifies treatment and may further improve their quality of life.
Unnecessary abdominal interventions in patients with hereditary angioedema.
J Dtsch Dermatol Ges
December 2018
Background: Hereditary angioedema (HAE) is a rare genetic disorder that leads to recurrent development of mucosal and dermal swelling. It is mediated by bradykinin, and can affect virtually any part of the human body, including the gastrointestinal tract, the extremities, and the laryngeal and pharyngeal regions. Safe and potent drugs are available for acute and prophylactic treatment of HAE.
View Article and Find Full Text PDF